按主题分类的文章 "GDC-1971"

1. GDC-1971: SHP2 Inhibitor Ushering in a New Era of Cancer Treatment
   发布于 2024年3月12日

   10
   In recent years, protein tyrosine phosphatase SHP2 has become a highly regarded research target in the field of oncology in mediating the RAS-driven MAPK signaling pathway. Its treatment methods are not limited to single drug use, but also can work together with KRAS inhibitors, showing good ...
2. GDC-1971——SHP2抑制剂引领癌症治疗新纪元
   发布于 2024年3月12日

   1
   近年来，蛋白酪氨酸磷酸酶SHP2在介导RAS驱动的MAPK信号转导过程中，已成为肿瘤学领域备受瞩目的研究靶点。其治疗方法不仅限于单药使用，还能与KRAS抑制剂共同协作，展现出良好的治疗潜力。